-
1
-
-
0036894435
-
Modifiable risk factors for colon cancer
-
Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 2002;31:925-943.
-
(2002)
Gastroenterol Clin North Am
, vol.31
, pp. 925-943
-
-
Giovannucci, E.1
-
2
-
-
33745904978
-
Targeted agents for adjuvant therapy of colon cancer
-
Saif MW. Targeted agents for adjuvant therapy of colon cancer. Clin Colorectal Cancer 2006;6:46-51.
-
(2006)
Clin Colorectal Cancer
, vol.6
, pp. 46-51
-
-
Saif, M.W.1
-
3
-
-
34249781974
-
Mesalazine downregulates c-Myc in human colon cancer cells. A key to its chemopreventive action?
-
Chu EC, Chai J, Ahluwalia A, Tarnawski AS. Mesalazine downregulates c-Myc in human colon cancer cells. A key to its chemopreventive action? Aliment Pharmacol Ther 2007;25:1443-1449.
-
(2007)
Aliment Pharmacol Ther
, vol.25
, pp. 1443-1449
-
-
Chu, E.C.1
Chai, J.2
Ahluwalia, A.3
Tarnawski, A.S.4
-
4
-
-
34548331823
-
Targeted therapy in rectal cancer
-
discussion 65, 70, 75 passim.
-
Willett CG, Duda DG, Czito BG, Bendell JC, Clark JW, Jain RK. Targeted therapy in rectal cancer. Oncology (Williston Park) 2007;21:1055-1065; discussion 65, 70, 75 passim.
-
(2007)
Oncology (Williston Park)
, vol.21
, pp. 1055-1065
-
-
Willett, C.G.1
Duda, D.G.2
Czito, B.G.3
Bendell, J.C.4
Clark, J.W.5
Jain, R.K.6
-
5
-
-
0036781812
-
c-MYC: more than just a matter of life and death
-
Pelengaris S, Khan M, Evan G. c-MYC: more than just a matter of life and death. Nat Rev Cancer 2002;2:764-776.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 764-776
-
-
Pelengaris, S.1
Khan, M.2
Evan, G.3
-
6
-
-
0037330625
-
Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes
-
Gartel AL, Shchors K. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res 2003;283:17-21.
-
(2003)
Exp Cell Res
, vol.283
, pp. 17-21
-
-
Gartel, A.L.1
Shchors, K.2
-
7
-
-
54349091392
-
Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition
-
Binion DG, Otterson MF, Rafiee P. Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. Gut 2008;57:1509-1517.
-
(2008)
Gut
, vol.57
, pp. 1509-1517
-
-
Binion, D.G.1
Otterson, M.F.2
Rafiee, P.3
-
8
-
-
4644350944
-
Unlocking the potential of the human genome with RNA interference
-
Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature 2004;431:371-378.
-
(2004)
Nature
, vol.431
, pp. 371-378
-
-
Hannon, G.J.1
Rossi, J.J.2
-
9
-
-
0037197914
-
RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells
-
Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci U S A 2002;99:6047-6052.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 6047-6052
-
-
Yu, J.Y.1
DeRuiter, S.L.2
Turner, D.L.3
-
10
-
-
0036351317
-
Analysis of gene function in somatic mammalian cells using small interfering RNAs
-
Elbashir SM, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 2002;26:199-213.
-
(2002)
Methods
, vol.26
, pp. 199-213
-
-
Elbashir, S.M.1
Harborth, J.2
Weber, K.3
Tuschl, T.4
-
11
-
-
0037025201
-
Sustained loss of a neoplastic phenotype by brief inactivation of MYC
-
Jain M, Arvanitis C, Chu K, Dewey W, Leonhardt E, Trinh M, Sundberg CD, Bishop JM, Felsher DW. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 2002;297:102-104.
-
(2002)
Science
, vol.297
, pp. 102-104
-
-
Jain, M.1
Arvanitis, C.2
Chu, K.3
Dewey, W.4
Leonhardt, E.5
Trinh, M.6
Sundberg, C.D.7
Bishop, J.M.8
Felsher, D.W.9
-
12
-
-
0033180211
-
Reversible tumorigenesis by MYC in hematopoietic lineages
-
Felsher DW, Bishop JM. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 1999;4:199-207.
-
(1999)
Mol Cell
, vol.4
, pp. 199-207
-
-
Felsher, D.W.1
Bishop, J.M.2
-
13
-
-
34247187543
-
Myc deletion rescues Apc deficiency in the small intestine
-
Sansom OJ, Meniel VS, Muncan V, Phesse TJ, Wilkins JA, Reed KR, Vass JK, Athineos D, Clevers H, Clarke AR. Myc deletion rescues Apc deficiency in the small intestine. Nature 2007;446:676-679.
-
(2007)
Nature
, vol.446
, pp. 676-679
-
-
Sansom, O.J.1
Meniel, V.S.2
Muncan, V.3
Phesse, T.J.4
Wilkins, J.A.5
Reed, K.R.6
Vass, J.K.7
Athineos, D.8
Clevers, H.9
Clarke, A.R.10
-
14
-
-
48549099080
-
C-Myc is a critical mediator of the phenotypes of Apc loss in the intestine
-
Wilkins JA, Sansom OJ. C-Myc is a critical mediator of the phenotypes of Apc loss in the intestine. Cancer Res 2008;68:4963-4966.
-
(2008)
Cancer Res
, vol.68
, pp. 4963-4966
-
-
Wilkins, J.A.1
Sansom, O.J.2
-
15
-
-
34247602358
-
Vascular endothelial growth factor inhibitors in colon cancer
-
Diaz-Rubio E. Vascular endothelial growth factor inhibitors in colon cancer. Adv Exp Med Biol 2006;587:251-275.
-
(2006)
Adv Exp Med Biol
, vol.587
, pp. 251-275
-
-
Diaz-Rubio, E.1
-
16
-
-
51849144987
-
c-myc antisense oligonucleotides sensitize human colorectal cancer cells to chemotherapeutic drugs
-
Abaza MS, Al-Saffar A, Al-Sawan S, Al-Attiyah R. c-myc antisense oligonucleotides sensitize human colorectal cancer cells to chemotherapeutic drugs. Tumour Biol 2008;29:287-303.
-
(2008)
Tumour Biol
, vol.29
, pp. 287-303
-
-
Abaza, M.S.1
Al-Saffar, A.2
Al-Sawan, S.3
Al-Attiyah, R.4
-
17
-
-
79952455505
-
The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy
-
van der Meel R, Symons MH, Kudernatsch R, Kok RJ, Schiffelers RM, Storm G, Gallagher WM, Byrne AT. The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy. Drug Discov Today 2011;16:219-228.
-
(2011)
Drug Discov Today
, vol.16
, pp. 219-228
-
-
van der Meel, R.1
Symons, M.H.2
Kudernatsch, R.3
Kok, R.J.4
Schiffelers, R.M.5
Storm, G.6
Gallagher, W.M.7
Byrne, A.T.8
-
18
-
-
68849084613
-
Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor
-
Shibuya M. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor. FEBS J 2009;276:4636-4643.
-
(2009)
FEBS J
, vol.276
, pp. 4636-4643
-
-
Shibuya, M.1
-
19
-
-
77955230057
-
Targeted therapy in advanced colorectal cancer: more data, more questions
-
Ochenduszko SL, Krzemieniecki K. Targeted therapy in advanced colorectal cancer: more data, more questions. Anticancer Drugs 21:737-748.
-
Anticancer Drugs
, vol.21
, pp. 737-748
-
-
Ochenduszko, S.L.1
Krzemieniecki, K.2
-
20
-
-
78149236063
-
Colorectal cancer: what progress can we anticipate in the next few years?
-
Bachet JB, Rougier P. Colorectal cancer: what progress can we anticipate in the next few years? Rev Prat 60:1111-1115.
-
Rev Prat
, vol.60
, pp. 1111-1115
-
-
Bachet, J.B.1
Rougier, P.2
-
21
-
-
0035942736
-
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
-
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-498.
-
(2001)
Nature
, vol.411
, pp. 494-498
-
-
Elbashir, S.M.1
Harborth, J.2
Lendeckel, W.3
Yalcin, A.4
Weber, K.5
Tuschl, T.6
-
22
-
-
1842505022
-
RNA interference: human genes hit the big screen
-
Fraser A. RNA interference: human genes hit the big screen. Nature 2004;428:375-378.
-
(2004)
Nature
, vol.428
, pp. 375-378
-
-
Fraser, A.1
|